Insulin-Like Growth Factor 1 Regulates Developing Brain Glucose Metabolism

The brain has enormous anabolic needs during early postnatal development. This study presents multiple lines of evidence showing that endogenous brain insulin-like growth factor 1 (Igf1) serves an essential, insulin-like role in promoting neuronal glucose utilization and growth during this period. B...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 97; no. 18; pp. 10236 - 10241
Main Authors Cheng, C M, Reinhardt, R R, Lee, W H, Joncas, G, Patel, S C, Bondy, C A
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences of the United States of America 29.08.2000
National Acad Sciences
National Academy of Sciences
The National Academy of Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The brain has enormous anabolic needs during early postnatal development. This study presents multiple lines of evidence showing that endogenous brain insulin-like growth factor 1 (Igf1) serves an essential, insulin-like role in promoting neuronal glucose utilization and growth during this period. Brain 2-deoxy-D-[1-14C]glucose uptake parallels Igf1 expression in wild-type mice and is profoundly reduced in Igf1-/- mice, particularly in those structures where Igf1 is normally most highly expressed. 2-Deoxy-D-[1-14C]glucose is significantly reduced in synaptosomes prepared from Igf1-/- brains, and the deficit is corrected by inclusion of Igf1 in the incubation medium. The serine/threonine kinase Akt/PKB is a major target of insulin-signaling in the regulation of glucose transport via the facilitative glucose transporter (GLUT4) and glycogen synthesis in peripheral tissues. Phosphorylation of Akt and GLUT4 expression are reduced in Igf1-/- neurons. Phosphorylation of glycogen synthase kinase 3β and glycogen accumulation also are reduced in Igf1-/- neurons. These data support the hypothesis that endogenous brain Igf1 serves an anabolic, insulin-like role in developing brain metabolism.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Edited by Louis Sokoloff, National Institutes of Health, Bethesda, MD, and approved June 16, 2000
To whom reprint requests should be addressed at: National Institutes of Health, Building 10/10N262, 10 Center Drive, Bethesda, MD 20892. E-mail: bondyc@exchange.nih.gov.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.170008497